Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
BMC Neurol ; 21(1): 274, 2021 Jul 09.
Article in English | MEDLINE | ID: mdl-34243715

ABSTRACT

BACKGROUND: Ischemic stroke, including transient ischemic attack (TIA) and acute-phase cerebral infarction (aCI), is a serious health problem in the aging society. Thus, this study aimed to identify TIA and aCI biomarkers. METHODS: In 19 patients with TIA, candidate antigens recognized by serum IgG autoantibodies were screened using a human aortic endothelial cell cDNA library. Through amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA), serum antibody levels against the candidate antigens were examined in healthy donor (HD), TIA, and aCI cohorts (n = 285, 92, and 529). The plasma antibody levels in the Japan Public Health Center-based Prospective Cohort Study (1991-1993) were also examined. RESULTS: The candidate antigens were aldolase A (ALDOA) and fumarate hydratase (FH). In AlphaLISA, patients with TIA or aCI had higher anti-ALDOA antibody (ALDOA-Ab) and anti-FH antibody (FH-Ab) levels than the HDs (P < 0.05). In a multivariate logistic regression analysis, the ALDOA-Ab (odds ratio [OR]: 2.46, P = 0.0050) and FH-Ab (OR: 2.49, P = 0.0037) levels were independent predictors of TIA. According to the case-control study, the ALDOA-Ab (OR: 2.50, P < 0.01) and FH-Ab (OR: 2.60, P < 0.01) levels were associated with aCI risk. In a correlation analysis, both ALDOA-Abs and FH-Abs were well associated with hypertension, coronary heart disease, and habitual smoking. These antibody levels also correlated well with maximum intima-media thickness, which reflects atherosclerotic stenosis. CONCLUSIONS: ALDOA-Abs and FH-Abs can be novel potential biomarkers for predicting atherosclerotic TIA and aCI.


Subject(s)
Autoantibodies/blood , Cerebral Infarction , Ischemic Attack, Transient , Biomarkers/blood , Case-Control Studies , Cerebral Infarction/blood , Cerebral Infarction/epidemiology , Fructose-Bisphosphate Aldolase/immunology , Humans , Ischemic Attack, Transient/blood , Ischemic Attack, Transient/epidemiology
2.
BMC Med ; 19(1): 131, 2021 06 09.
Article in English | MEDLINE | ID: mdl-34103026

ABSTRACT

BACKGROUND: Acute ischemic stroke (AIS) is a serious cause of mortality and disability. AIS is a serious cause of mortality and disability. Early diagnosis of atherosclerosis, which is the major cause of AIS, allows therapeutic intervention before the onset, leading to prevention of AIS. METHODS: Serological identification by cDNA expression cDNA libraries and the protein array method were used for the screening of antigens recognized by serum IgG antibodies in patients with atherosclerosis. Recombinant proteins or synthetic peptides derived from candidate antigens were used as antigens to compare serum IgG levels between healthy donors (HDs) and patients with atherosclerosis-related disease using the amplified luminescent proximity homogeneous assay-linked immunosorbent assay. RESULTS: The first screening using the protein array method identified death-inducer obliterator 1 (DIDO1), forkhead box J2 (FOXJ2), and cleavage and polyadenylation specificity factor (CPSF2) as the target antigens of serum IgG antibodies in patients with AIS. Then, we prepared various antigens including glutathione S-transferase-fused DIDO1 protein as well as peptides of the amino acids 297-311 of DIDO1, 426-440 of FOXJ2, and 607-621 of CPSF2 to examine serum antibody levels. Compared with HDs, a significant increase in antibody levels of the DIDO1 protein and peptide in patients with AIS, transient ischemic attack (TIA), and chronic kidney disease (CKD) but not in those with acute myocardial infarction and diabetes mellitus (DM). Serum anti-FOXJ2 antibody levels were elevated in most patients with atherosclerosis-related diseases, whereas serum anti-CPSF2 antibody levels were associated with AIS, TIA, and DM. Receiver operating characteristic curves showed that serum DIDO1 antibody levels were highly associated with CKD, and correlation analysis revealed that serum anti-FOXJ2 antibody levels were associated with hypertension. A prospective case-control study on ischemic stroke verified that the serum antibody levels of the DIDO1 protein and DIDO1, FOXJ2, and CPSF2 peptides showed significantly higher odds ratios with a risk of AIS in patients with the highest quartile than in those with the lowest quartile, indicating that these antibody markers are useful as risk factors for AIS. CONCLUSIONS: Serum antibody levels of DIDO1, FOXJ2, and CPSF2 are useful in predicting the onset of atherosclerosis-related AIS caused by kidney failure, hypertension, and DM, respectively.


Subject(s)
Antibodies , Brain Ischemia , Ischemic Stroke , Stroke , Antibodies/blood , Brain Ischemia/diagnosis , Case-Control Studies , Cleavage And Polyadenylation Specificity Factor/immunology , DNA-Binding Proteins/immunology , Forkhead Transcription Factors/immunology , Humans , Stroke/diagnosis
3.
Cancer Sci ; 111(12): 4453-4464, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32939876

ABSTRACT

Some cancers are related to atherosclerotic diseases; therefore, these two types of disease may share some antibody biomarkers in common. To investigate this, a first screening of sera was performed from patients with esophageal squamous cell carcinoma (ESCC) or acute ischemic stroke (AIS) for serological identification of antigens using recombinant cDNA expression cloning (SEREX). The amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA) method, which incorporates glutathione donor beads and anti-human IgG acceptor beads, was used to evaluate serum antibody levels. SEREX screening identified low-density lipoprotein receptor-related protein-associated protein 1 (LRPAP1) as a target antigen of serum IgG antibodies in the sera of patients with ESCC or AIS. Antigens, including recombinant glutathione S-transferase-fused LRPAP1 protein, were prepared to examine serum antibody levels. AlphaLISA revealed significantly higher antibody levels against the LRPAP1 protein in patients with solid cancers such as ESCC and colorectal carcinoma and some atherosclerosis-related diseases such as AIS and diabetes mellitus compared with healthy donors. Correlation analysis revealed that the elevated serum antibody levels against LRPAP1 were associated with smoking, a well-known risk factor for both cancer and atherosclerosis. Serum LRPAP1 antibody is therefore a common marker for the early diagnosis of some cancers and atherosclerotic diseases and may reflect diseases caused by habitual smoking.


Subject(s)
Esophageal Neoplasms/blood , Esophageal Squamous Cell Carcinoma/blood , Immunoglobulin G/blood , Ischemic Stroke/blood , LDL-Receptor Related Protein-Associated Protein/immunology , Acute Disease , Biomarkers/blood , Colorectal Neoplasms/blood , Colorectal Neoplasms/immunology , DNA, Complementary , Esophageal Neoplasms/immunology , Esophageal Squamous Cell Carcinoma/immunology , Humans , Immunoenzyme Techniques , Ischemic Stroke/immunology , Neoplasm Proteins/immunology
4.
Oncotarget ; 9(5): 5600-5613, 2018 Jan 19.
Article in English | MEDLINE | ID: mdl-29464021

ABSTRACT

Transient ischemic attack (TIA) is a predictor for cerebral infarction (CI), and early diagnosis of TIA is extremely important for the prevention of CI. We set out to identify novel antibody biomarkers for TIA and CI, and detected matrix metalloproteinase 1 (MMP1), chromobox homolog 1 (CBX1), and chromobox homolog 5 (CBX5) as candidate antigens using serological identification of antigens by recombinant cDNA expression cloning (SEREX) and Western blotting to confirm the presence of serum antibodies against the antigens. Amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA) revealed that serum antibody levels were significantly higher in patients with TIA or acute-phase CI (aCI) compared with healthy donors (P < 0.01). Spearman's correlation analysis and multivariate logistic regression analysis demonstrated that levels of anti-MMP1, anti-CBX1, and anti-CBX5 antibodies were associated with age, cigarette-smoking habits, and blood pressure. Thus, serum levels of antibodies against MMP1, CBX1, and CBX5 could potentially serve as useful tools for diagnosing TIA and predicting the onset of aCI.

5.
J Toxicol Sci ; 42(6): 689-705, 2017.
Article in English | MEDLINE | ID: mdl-29142168

ABSTRACT

To obtain background data of NOD/Shi-scid IL-2Rγnull (NOG) mice, severely immunedeficient mice, a total of 120 animals were examined at 7, 26 and 52 weeks-old (20 mice/sex/group). The survival rate at 52 weeks-old was 95% (19/20) in both sexes. Clinically, circling behavior in one direction along the cage wall was observed in males after 8 weeks and females after 47 weeks-old, and hunchback position was found in males after 32 weeks-old. Hematologically, lymphocyte count markedly decreased at all ages, while white blood cell count increased in several mice at 52 weeks-old. Blood chemistry results revealed high values of aspartate aminotransferase, lactate dehydrogenase and creatine phosphokinase in some females at 26 weeks-old, without any related histological change. Histologically, lymphoid hypoplasia characterized by severe lymphocyte depletion with poorly developed tissue architectures was observed. In addition, spongiotic change in the nerve tissue was observed in both sexes at 7 and 26 weeks-old, and intracytoplasmic materials known as tubular aggregates in the skeletal muscles were found in males terminated at 26 and 52 weeks-old and in females at 52 weeks-old. Malignant lymphoma was found in one female euthanized at 20 weeks-old. Further, small intestinal adenoma, hepatocellular adenoma, leukemia, cerebral lipomatous hamartoma, Harderian gland adenoma and uterine polyp were also observed, and their incidences were low except for that of uterine polyp. This study provided detailed background data on NOG mice up to 52 weeks-old and provided information on appropriate use of NOG mice in the various research fields.


Subject(s)
Mice, Inbred NOD , Mice, SCID , Animals , Aspartate Aminotransferases/blood , Behavior, Animal/physiology , Creatine Kinase/blood , Female , Intestinal Neoplasms/pathology , L-Lactate Dehydrogenase/blood , Leukemia , Leukocyte Count , Liver Neoplasms/pathology , Locomotion/physiology , Lymphatic System/pathology , Lymphocyte Count , Lymphoma/pathology , Male , Mice, Inbred NOD/blood , Mice, Inbred NOD/physiology , Mice, Inbred NOD/psychology , Mice, SCID/blood , Mice, SCID/physiology , Mice, SCID/psychology , Muscle, Skeletal/cytology , Muscle, Skeletal/pathology , Myopathies, Structural, Congenital/pathology , Nerve Tissue/pathology , Posture/physiology
6.
Article in English | MEDLINE | ID: mdl-27931808

ABSTRACT

As a part of a collaborative study of the Pig-a assay by the Mammalian Mutagenicity Study Group of the Japanese Environmental Mutagen Society, a genotoxicity study on acetaminophen (APAP) was performed using the red blood cell (RBC) Pig-a and PIGRET assays. The dose levels were set at 0 (vehicle, 0.5% methylcellulose solution), 500, 1000, and 2000mg/kg, and APAP was administered once by oral gavage to male Sprague Dawley rats. For the positive control group, N-nitroso-N-ethylurea (ENU, 40mg/kg) was administered in the same way. The RBC Pig-a and PIGRET assays were performed using peripheral blood collected at pre-dosing and 1, 2 and 4 weeks after dosing. In both the RBC Pig-a and PIGRET assays, there were no changes in the Pig-a gene mutant frequency (MF) by the APAP treatment at any time point. The Pig-a MFs as measured by the RBC Pig-a assay for the ENU-treated group increased in a time-dependent manner with the maximum value at week 4; however, those using the PIGRET assay reached comparable values at week 1. Based on the above results, APAP was determined to have no mutagenicity under the conditions of this study, and the PIGRET assay could detect mutagenicity of ENU much earlier than the RBC Pig-a assay.


Subject(s)
Acetaminophen/toxicity , Erythrocytes/drug effects , Membrane Proteins/genetics , Mutagenicity Tests/methods , Reticulocytes/drug effects , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Rats
7.
Article in English | MEDLINE | ID: mdl-27931811

ABSTRACT

The in vivo mutation assay using the X-linked phosphatidylinositol glycan class A gene (Pig-a in rodents, PIG-A in humans) is a promising tool for evaluating the mutagenicity of chemicals. Approaches for measuring Pig-a mutant cells have focused on peripheral red blood cells (RBCs) and reticulocytes (RETs) from rodents. The recently developed PIGRET assay is capable of screening >1×106 RETs for Pig-a mutants by concentrating RETs in whole blood prior to flow cytometric analysis. Additionally, due to the characteristics of erythropoiesis, the PIGRET assay can potentially detect increases in Pig-a mutant frequency (MF) sooner after exposure compared with a Pig-a assay targeting total RBCs (RBC Pig-a assay). In order to test the merits and limitations of the PIGRET assay as a short-term genotoxicity test, an interlaboratory trial involving 16 laboratories was organized by the Mammalian Mutagenicity Study Group of the Japanese Environmental Mutagenicity Society (MMS/JEMS). First, the technical proficiency of the laboratories and transferability of the assay were confirmed by performing both the PIGRET and RBC Pig-a assays on rats treated with single doses of N-nitroso-N-ethylurea. Next, the collaborating laboratories used the PIGRET and RBC Pig-a assays to assess the mutagenicity of a total of 24 chemicals in rats, using a single treatment design and mutant analysis at 1, 2, and 4 weeks after the treatment. Thirteen chemicals produced positive responses in the PIGRET assay; three of these chemicals were not detected in the RBC Pig-a assay. Twelve chemicals induced an increase in RET Pig-a MF beginning 1 week after dosing, while only 3 chemicals positive for RBC Pig-a MF produced positive responses 1 week after dosing. Based on these results, we conclude that the PIGRET assay is useful as a short-term test for in vivo mutation using a single-dose protocol.


Subject(s)
Laboratories/organization & administration , Membrane Proteins/genetics , Mutagenicity Tests/methods , Mutation , Reticulocytes/drug effects , Erythrocytes/drug effects , Ethylnitrosourea/toxicity , Humans , Interinstitutional Relations , Reproducibility of Results
8.
Mutat Res Genet Toxicol Environ Mutagen ; 811: 97-101, 2016 Nov 15.
Article in English | MEDLINE | ID: mdl-27931823

ABSTRACT

As a part of a collaborative study of the Pig-a assay by the Mammalian Mutagenicity Study Group of the Japanese Environmental Mutagen Society, a genotoxicity study on cisplatin was performed using red blood cell (RBC) Pig-a and PIGRET assays. The dose levels were set at 0 (vehicle, physiological saline), 0.5, 1, and 2 mg/kg, and cisplatin was administered intravenously once to male F344 rats. The RBC Pig-a and PIGRET assays were performed using peripheral blood collected at pre-dosing and 1, 2 and 4 weeks after dosing. In the RBC Pig-a assay, an increase in the Pig-a mutant frequency (MF) was observed at week 4 in the high dose group. Although a significant increase in the Pig-a MF was also observed at week 2 in all cisplatin-treated groups, it was considered that this change was caused by a low MF in the vehicle control group and not to be biologically relevant. In the PIGRET assay, the Pig-a MF was increased at weeks 1, 2 and 4 in the high dose group. In addition, the means of the vehicle control group's Pig-a MFs in the PIGRET assay were lower than those in the RBC Pig-a assay. Based on the above results, cisplatin was determined to have mutagenicity under the conditions of this study, and it was demonstrated that the PIGRET assay was an appropriate tool to evaluate the in vivo mutagenicity much earlier than the RBC Pig-a assay.


Subject(s)
Cisplatin/toxicity , Erythrocytes/drug effects , Membrane Proteins/genetics , Mutagenicity Tests/methods , Mutagens/toxicity , Reticulocytes/drug effects , Animals , Dose-Response Relationship, Drug , Male , Rats , Rats, Inbred F344
9.
Intern Med ; 52(6): 667-71, 2013.
Article in English | MEDLINE | ID: mdl-23503408

ABSTRACT

A 64-year-old man undergoing chronic hemodialysis was admitted under a shock state with macrohematuria and fatigue lasting for two hours. A blood analysis revealed severe anemia. Computed tomography disclosed a large right-sided perirenal hematoma. The patient was successfully treated with radical nephrectomy, leading to a histological diagnosis of spontaneous rupture of renal cell carcinoma (RCC). One year after rupture of the right RCC, he again developed macrohematuria and computed tomography revealed a left-sided perirenal hematoma. Radical nephrectomy followed by a histological examination revealed spontaneous rupture of the left-sided RCC. This case emphasizes the importance of conducting periodic imaging evaluations of chronic hemodialysis patients with renal cystic masses.


Subject(s)
Carcinoma, Renal Cell/pathology , Kidney Neoplasms/pathology , Neoplasms, Multiple Primary/pathology , Anemia/etiology , Anemia/therapy , Aspirin/adverse effects , Blood Transfusion , Carcinoma, Renal Cell/complications , Carcinoma, Renal Cell/surgery , Glomerulonephritis/complications , Hematuria/etiology , Humans , Kidney Failure, Chronic/etiology , Kidney Failure, Chronic/therapy , Kidney Neoplasms/complications , Kidney Neoplasms/surgery , Male , Middle Aged , Neoplasms, Multiple Primary/complications , Neoplasms, Multiple Primary/surgery , Nephrectomy , Platelet Aggregation Inhibitors/adverse effects , Polycystic Kidney Diseases/etiology , Renal Dialysis , Rupture, Spontaneous , Shock, Hemorrhagic/chemically induced , Shock, Hemorrhagic/etiology
10.
Reprod Toxicol ; 34(3): 408-19, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22561194

ABSTRACT

To examine the effects of developmental manganese (Mn)-exposure on hippocampal neurogenesis, pregnant rats were treated with MnCl(2)·4H(2)O in the diet at 32, 160 or 800 ppm from gestation day 10 to day 21 after delivery. Serum concentrations of thyroid-related hormones were examined in offspring exposed to MnCl(2)·4H(2)O at 800 or 1600 ppm. Immunohistochemical analysis revealed increased doublecortin-positive cells in the subgranular zone of the dentate gyrus on postnatal day (PND) 21 following exposure to MnCl(2)·4H(2)O at 800 ppm, indicating an increase of type-3 progenitor or immature granule cells. Reelin-positive cells, suggestive of γ-aminobutyric acid-ergic interneurons in the dentate hilus, also increased at 800 ppm on PND 21. Brain Mn concentrations increased in offspring on PND 21 at 160 and 800 ppm, whereas brain concentrations in the dams were unchanged. Serum concentrations of triiodothyronine and thyroxine decreased at 800 and 1600 ppm, whereas thyroid-stimulating hormone increased only after exposure at 800 ppm. All changes disappeared on PND 77. Thus, maternal exposure to MnCl(2)·4H(2)O at 800 ppm mildly and reversibly affects neurogenesis targeting late-stage differentiation in the hippocampal dentate gyrus of rat offspring. Direct effects of accumulated Mn in the developing brain might be implicated in the mechanism of the development of aberrations in neurogenesis; however, indirect effects through thyroid hormone fluctuations might be rather minor.


Subject(s)
Chlorides/toxicity , Dentate Gyrus/drug effects , Neurogenesis/drug effects , Animals , Animals, Newborn , Apoptosis/drug effects , Cell Proliferation/drug effects , Cerebellum/metabolism , Dentate Gyrus/growth & development , Doublecortin Protein , Female , Male , Manganese Compounds , Maternal-Fetal Exchange , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Reelin Protein , Reflex, Righting/drug effects , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood
11.
Toxicol Mech Methods ; 22(4): 289-95, 2012 May.
Article in English | MEDLINE | ID: mdl-22500783

ABSTRACT

Serum alkaline phosphatase (ALP) activity is frequently measured in toxicity studies. In the present study, we assessed the usefulness of a commercially available polyacrylamide-gel disk electrophoresis kit used in humans (AlkPhor System, Jokoh Co. Ltd., Tokyo, Japan) for identifying serum ALP isoenzymes in rats of the Sprague-Dawley strain (SD rats), which are commonly used in toxicity studies. We also examined age-related changes in serum ALP isoenzymes in SD rats. In order to identify the origin of each ALP isoenzyme, tissue ALP extracts from the liver, bone and small intestine (SI) and serum samples were treated with neuraminidase, antiintestinal ALP antibody, ALP inhibitor levamisole, and/or wheat germ agglutinin. It became clear that pretreatment of serum with neuraminidase is necessary for rat serum ALP isoenzyme analysis. The kit revealed that the main serum ALP isoenzymes in fasted 8-week-old intact rats were bone- and SI-derived and they tended to decrease with age. Serum liver-derived isoenzyme was slightly detected in both sexes of all ages examined, but it greatly increased in cholestasis model rats with bile-duct ligation, and rats of this model also had large molecular ALP detected in the stacking gel, suggesting hepatic damage. High-molecular intestinal ALP isoenzyme was slightly observed at the most cathodal side of the resolving gel. These results suggest that the present method is a useful tool for detecting serum ALP isoenzymes in SD rats and that concomitant levamisole inhibition with another gel is applicable for the evaluation of organ toxicity.


Subject(s)
Alkaline Phosphatase/classification , Electrophoresis, Polyacrylamide Gel/methods , Aging , Alkaline Phosphatase/metabolism , Animals , Biomarkers , Bone and Bones/enzymology , Female , Gene Expression Regulation, Enzymologic , Intestine, Small/enzymology , Isoenzymes , Liver/enzymology , Male , Rats , Rats, Sprague-Dawley , Specific Pathogen-Free Organisms
12.
J Orthop Surg Res ; 7: 9, 2012 Feb 22.
Article in English | MEDLINE | ID: mdl-22356935

ABSTRACT

BACKGROUND: Total knee arthroplasty (TKA) is a common form of treatment to relieve pain and improve function in cases of rheumatoid arthritis (RA). Good clinical outcomes have been reported with a variety of TKA prostheses. The cementless Hi-Tech Knee II cruciate-retaining (CR)-type prosthesis, which has 6 fins at the anterior of the femoral component, posterior cruciate ligament (PCL) retention, flat-on-flat surface component geometry, all-polyethylene patella, strong initial fixation by the center screw of the tibial base plate, 10 layers of titanium alloy fiber mesh, and direct compression molded ultra high molecular weight polyethylene (UHMWPE), is appropriate for TKA in the Japanese knee.The present study was performed to evaluate the clinical results of primary TKA in RA using the cementless Hi-Tech Knee II CR-type prosthesis. MATERIALS AND METHODS: We performed 32 consecutive primary TKAs using cementless Hi-Tech Knee II CR-type prosthesis in 31 RA patients. The average follow-up period was 8 years 3 months. Clinical evaluations were performed according to the American Knee Society (KS) system, knee score, function score, radiographic evaluation, and complications. RESULTS: The mean postoperative maximum flexion angle was 115.6°, and the KS knee score and function score improved to 88 and 70 after surgery, respectively. Complications, such as infection, occurred in 1 patient and revision surgery was performed. There were no cases of loosening in this cohort, and prosthesis survival rate was 96.9% at 12 years postoperatively. CONCLUSION: These results suggest that TKA using the cementless Hi-Tech Knee II CR-type prosthesis is a very effective form of treatment in RA patients at 5 to 12 years postoperatively. Further long-term follow-up studies are required to determine the ultimate utility of this type of prosthesis.


Subject(s)
Arthritis, Rheumatoid/surgery , Arthroplasty, Replacement, Knee/methods , Knee Prosthesis , Adult , Aged , Arthroplasty, Replacement, Knee/adverse effects , Arthroplasty, Replacement, Knee/instrumentation , Cementation , Female , Follow-Up Studies , Humans , Knee Joint/diagnostic imaging , Knee Joint/physiopathology , Knee Joint/surgery , Male , Middle Aged , Prosthesis Design , Radiography , Treatment Outcome
13.
J Toxicol Sci ; 36(5): 653-60, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22008540

ABSTRACT

Serum alkaline phosphatase (ALP) activity is frequently measured in toxicity studies. Itoh et al. (2002) reported that a commercially available polyacrylamide-gel (PAG) disk electrophoresis kit used in humans (AlkPhor System, Jokoh Co., Ltd., Tokyo, Japan) for identifying serum ALP isoenzymes was useful for veterinary clinicopathological diagnosis in mongrel dogs. In the present study, based on the report of Itoh et al. (2002), we tried to expand the application range of this kit to laboratory beagle dogs which are commonly used in toxicity studies. In order to identify the origin of each ALP isoenzyme, tissue ALP extracts from the liver, bone and small intestine and serum samples were treated with neuraminidase, anti-small intestinal ALP antibody, ALP inhibitor levamisole and/or wheat germ agglutinin (WGA). The main serum ALP isoenzymes in 5-month-old intact beagle dogs were bone-derived (bone and atypical ALP: corresponding to human variant bone ALP) and they tended to decrease with age. However, liver-derived ALP isoenzyme greatly increased in the serum of cholestasis model dogs. The cholestasis model dogs also had a large molecular ALP detected in the resolving gel. This ALP could be originated from intestinal ALP or corticosteroid-induced ALP (CALP), because the activity remained even after levamisole inhibition. CALP was observed in intact laboratory beagle dogs with individual differences. These results suggest that the present method is a useful tool for detecting serum ALP isoenzymes in laboratory beagle dogs and concomitant levamisole inhibition with another gel is applicable for the evaluation of organ toxicity.


Subject(s)
Alkaline Phosphatase/blood , Electrophoresis, Polyacrylamide Gel , Aging/blood , Alkaline Phosphatase/metabolism , Animals , Bone and Bones/enzymology , Cholestasis/blood , Cholestasis/enzymology , Disease Models, Animal , Dogs , Female , Intestine, Small/enzymology , Isoenzymes , Levamisole/pharmacology , Liver/enzymology , Male , Neuraminidase/pharmacology , Organ Specificity , Toxicity Tests/methods , Wheat Germ Agglutinins/pharmacology
14.
J Toxicol Sci ; 36(2): 211-9, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21467748

ABSTRACT

Plasma alkaline phosphatase (ALP) activity is frequently measured in toxicity studies. In the present study, we assessed the usefulness of a commercially available polyacrylamide-gel (PAG) disk electrophoresis kit used in humans (AlkPhor System, Jokoh Co., Ltd., Tokyo, Japan) for identifying plasma ALP isoenzymes in mice of the Crlj:CD1 strain (ICR mice), which are commonly used in toxicity studies. We also examined age-related changes in plasma ALP isoenzymes in ICR mice. Electrophoresis was performed according to the manufacturer's instructions. In order to identify the origin of each ALP isoenzyme, in addition to plasma samples, tissue ALP extracts from the liver, bone and small intestine were treated with neuraminidase, anti-small intestinal ALP antibody, ALP inhibitor levamisole and/or wheat germ agglutinin (WGA). The kit revealed that main plasma ALP isoenzyme in intact ICR mice was bone-derived one, and it tended to decrease with age. On the other hand, liver-derived ALP isoenzyme greatly increased in plasma of cholestasis model mice induced by bile duct ligation. This model mouse had also a large molecular ALP detected in the stacking gel. This ALP was thought to be of intestinal origin because its activity remained even after levamisole inhibition. In addition, a minimum sample volume for sufficient resolution of plasma ALP isoenzymes was only 14µl. The results of this study suggest that the present method is a useful tool for detecting plasma ALP isoenzymes in mice and that pre-treatment of plasma with neuraminidase and concomitant levamisole inhibition with another gel is applicable for the evaluation of organ toxicity.


Subject(s)
Alkaline Phosphatase/blood , Electrophoresis, Disc/methods , Aging/physiology , Alkaline Phosphatase/antagonists & inhibitors , Animals , Bone and Bones/chemistry , Bone and Bones/enzymology , Cholestasis/enzymology , Cholestasis/etiology , Disease Models, Animal , Female , Intestine, Small/chemistry , Intestine, Small/enzymology , Isoenzymes , Levamisole/metabolism , Levamisole/pharmacology , Liver/chemistry , Liver/enzymology , Male , Mice , Mice, Inbred ICR , Reagent Kits, Diagnostic , Tissue Extracts/chemistry
15.
Rheumatol Int ; 30(3): 409-13, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19826823

ABSTRACT

The present study was performed to evaluate the synovium in patients with rheumatoid arthritis (RA) treated with anti-tumor necrosis factor alpha agents (anti-TNFalpha). Synovial tissue specimens were obtained during total knee arthroplasty (TKA) from 42 RA patients (12 men, 30 women). Twenty-one RA patients were given anti-TNFalpha agents (infliximab, n = 12; etanercept, n = 9), while the remaining 21 RA patients were given no such agents.The histopathological findings were compared between specimens from these groups using the histological scoring system reported by Rooney, which consists of six items:degree of synovial hyperplasia, fibrosis, number of blood vessels, perivascular lymphocyte infiltration, focal aggregates of lymphocytes, and diffuse infiltrates of lymphocytes.Clinical laboratory data including C-reactive protein(CRP), matrix metalloproteinase-3 (MMP-3), and disease activity scores including a 28-joint count (DAS28), disease duration, methotrexate (MTX) dose, and glucocorticoid dose were also assessed before surgery. There were no significant differences in total score between anti-TNFalpha and no anti-TNFalpha groups. However, significant differences were observed in scores of synoviocyte hyperplasia and perivascular infiltrates of lymphocytes between the groups. These results suggested that these agents have a suppressive effect on cell proliferation in the lining layer and on perivascular lymphocyte infiltration. However, further studies are necessary to elucidate the mechanisms of these effects.


Subject(s)
Antibodies, Monoclonal/pharmacology , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/pathology , Knee Joint/drug effects , Knee Joint/pathology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Aged , Antibodies, Monoclonal/therapeutic use , Antirheumatic Agents/pharmacology , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/physiopathology , Arthroplasty, Replacement, Knee , Biomarkers/analysis , Biomarkers/metabolism , Biopsy , C-Reactive Protein/analysis , C-Reactive Protein/metabolism , Cell Proliferation/drug effects , Chemotaxis, Leukocyte/drug effects , Chemotaxis, Leukocyte/immunology , Female , Glucocorticoids/administration & dosage , Humans , Hyperplasia/drug therapy , Hyperplasia/physiopathology , Hyperplasia/prevention & control , Infliximab , Knee Joint/physiopathology , Lymphocyte Activation/drug effects , Lymphocyte Activation/immunology , Lymphocytes/drug effects , Lymphocytes/immunology , Lymphocytes/pathology , Male , Matrix Metalloproteinase 3/analysis , Matrix Metalloproteinase 3/metabolism , Methotrexate/administration & dosage , Middle Aged , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/pathology , Neovascularization, Pathologic/physiopathology , Outcome Assessment, Health Care/methods , Synovial Membrane/drug effects , Synovial Membrane/pathology , Synovial Membrane/physiopathology
16.
Ageing Res Rev ; 9(2): 91-100, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19800033

ABSTRACT

Microalgae that divide symmetrically in all aspects do not age. While the evolutionary reason for this is obvious, little attention has been paid to the mechanistic explanations. A great deal of study involving many research fields would be needed to explain the mechanisms if we suppose that the immortality results from a lifelong sufficiency of defense from stress or from an essential part of counteracting age-accompanied damage accumulation. Additionally, little is known about the relationships between homeostasis and circadian clocks in antiaging, although each of these has been studied separately. Here, we present a conceptual generalization of those relationships, as suggested by evidence from non-aging microalgae, mainly Euglena. The circadian gating of mitosis and circadian temporal coordination may respectively reduce radiation- and disharmony-induced stress in which homeostasis cannot be involved, whereas circadian resistance rhythms may greatly help homeostatic defense from radiation- and metabolism-induced stress. We also briefly sketch mammalian aging research to compare the current status of knowledge with that of algal antiaging.


Subject(s)
Biological Clocks/physiology , Cellular Senescence/physiology , Circadian Rhythm/physiology , Euglena/physiology , Homeostasis/physiology , Cellular Senescence/radiation effects , Euglena/radiation effects , Mitosis/physiology , Oxidative Stress/physiology , Stress, Physiological/physiology , Stress, Physiological/radiation effects , Ultraviolet Rays
17.
Bone ; 43(5): 832-9, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18725334

ABSTRACT

Most studies have focused on the association between diabetes mellitus (DM) and impaired osseous healing, but there is also evidence that diabetes impairs cartilage formation during fracture healing. To investigate the molecular mechanisms by which diabetes affects endochondral ossification, experiments were performed in a model of rat closed fracture healing complicated with diabetes. Diabetic rats were created by a single intravenous injection of streptozotocin (STZ), while controls were treated with vehicle alone. Fractures were made 2 weeks after STZ injection. Animals were killed at 4, 7, 10, 14, 21, 28 and 42 days following fracture, and samples were subject to radiographic, histological and molecular analyses. In the DM group, a significantly smaller cartilaginous callus was formed compared with controls throughout healing, with the cartilage area being reduced rapidly after day 14. When the bone union rate was evaluated radiographically on day 28, DM calluses exhibited a lower rate than controls. However, when evaluated on day 42, both groups showed an equivalent union rate. Cellular proliferation of chondroprogenitor cells and proliferating chondrocytes in soft calluses of the DM group was significantly reduced during early stages of healing (days 4 and 7), but no longer reduced thereafter. Moreover, expression levels of collagen type II, type X and osteopontin (OPN) were constantly low in the DM group. These results show the molecular basis for diminished cartilage formation and delayed union in fracture healing of the STZ-induced diabetic rats.


Subject(s)
Cartilage/physiology , Femur/anatomy & histology , Fracture Healing , Animals , Biomarkers/metabolism , Bony Callus/cytology , Bony Callus/physiology , Cartilage/cytology , Diabetes Mellitus, Experimental , Femur/diagnostic imaging , Femur/pathology , Osteopontin/genetics , Osteopontin/metabolism , Radiography , Rats , Rats, Sprague-Dawley
18.
J Toxicol Sci ; 33(3): 307-14, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18670162

ABSTRACT

Effects of dose and duration of phenobarbital (PB) administration and those of co-administration of PB and vitamin K on blood coagulation-related parameters were examined in specific pathogen-free (SPF) rats of Sprague-Dawley strain kept on an ordinary diet. In Experiment 1, oral administration of PB (0, 25, 50, 100 or 150 mg/kg/day) for 2 weeks induced increases in hepatic cytochrome P450 content and CYP2B expression, prolongation of coagulation time (activated partial thromboplastin time (APTT) and Thrombotest (TBT)) and an increase in anti-thrombin III (AT III) concentration in a dose-dependent manner. In Experiment 2, PB administration (100 mg/kg/day) for up to 14 days produced time-dependent increases in hepatic cytochrome P450 content and CYP2B (CYP2B1 and CYP2B2) expression. APTT was prolonged from day 1 and AT III concentration was increased from day 2, whereas the coagulation time (TBT) was prolonged from day 7. In Experiment 3, APTT prolonged by PB (100 mg/kg/day) was shortened after vitamin K(2) (30 mg/kg/day) co-administration, although AT III concentration was still increased. This suggests that not AT III but PB-induced vitamin K deficiency may play an important role in PB-induced prolongation of coagulation time in SPF rats kept on an ordinary diet.


Subject(s)
Blood Coagulation/drug effects , Phenobarbital/toxicity , Vitamin K/pharmacology , Animals , Antithrombin III/analysis , Antithrombin III/physiology , Dose-Response Relationship, Drug , Male , Partial Thromboplastin Time , Rats , Rats, Sprague-Dawley , Specific Pathogen-Free Organisms , Vitamin K/metabolism
19.
J Urol ; 180(3): 904-9; discussion 909-10, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18635221

ABSTRACT

PURPOSE: We validated the 2001 Partin tables and developed an original nomogram for Japanese patients using the 2005 International Society of Urological Pathology consensus on Gleason grading. MATERIALS AND METHODS: Prostatectomy specimens from 1,188 Japanese men who underwent radical prostatectomy for clinically localized prostate cancer (cT1-2) between 1997 and 2005 were analyzed. Polychotomous logistic regression analysis was used to construct a nomogram to predict final pathological stage (organ confined disease, extraprostatic extension, seminal vesicle invasion and lymph node involvement) from 3 variables, including serum prostate specific antigen, clinical stage and biopsy Gleason score. The area under the ROC curve was used to compare the new nomogram with the Partin tables. RESULTS: Preoperative serum prostate specific antigen and biopsy Gleason score were higher in the Japanese cohort than in the Partin cohort. The distribution of clinical and final pathological stages was similar in the 2 cohorts. The AUC for predicting organ confined disease was 0.699 and 0.717 for data applied to the Partin tables and to the new nomogram, respectively. The AUC for predicting lymph node involvement was 0.793 and 0.863, respectively. CONCLUSIONS: To our knowledge this is the first preoperative nomogram developed for clinically localized prostate cancer in Japanese patients. Although the new nomogram predicted the pathological stage of prostate cancer in Japanese patients more accurately than the Partin tables, it did not satisfactorily predict organ confined disease. However, other predictive variables, such as more detailed pathological features of biopsy specimens or magnetic resonance imaging, may further improve prediction accuracy.


Subject(s)
Prostatic Neoplasms/pathology , Area Under Curve , Humans , Japan , Logistic Models , Male , Neoplasm Staging , Nomograms , Predictive Value of Tests , Preoperative Care , Prostatectomy , Prostatic Neoplasms/surgery , ROC Curve , Sensitivity and Specificity
20.
Anticancer Res ; 27(5A): 3227-33, 2007.
Article in English | MEDLINE | ID: mdl-17970065

ABSTRACT

We previously performed SEREX (serological identification of antigens by recombinant expression cloning) using the sera of patients with esophageal squamous cell carcinoma (SCC), and isolated a variant clone (AK093616) of ubiquitin-conjugating enzyme E21 (UBE2I). This clone was tentatively designated as UBE2I-v5 and analyzed for biological function by transient transfection of the cDNA into activated Ha-ras-transformed NIH3T3 (ras-NIH) mouse fibroblasts. Chemosensitivity to 92 cytotoxic drugs was compared between UBE2I-v5-transfected cells and the parental ras-NIH cells. The UBE2I-v5-transfected cells were more sensitive than the parental cells to anticancer drugs such as vincristine (VCR), mitoxantrone (MIT) and etoposide (VP16). The regression analysis of the total chemosensitivity pattern of UBE2I-vS-transfected cells revealed that the function of UBE2I-v5 was positively related to RPA2 (replication protein A2), Rho-GDI (Rho guanine nucleotide dissociation inhibitor a), FUS (putative tumor suppressor) and TKT (transketolase) but negatively related to Per-1 (period-I), Ran (nuclear Ras-related protein), PTEN (phosphatase and tensin homolog), C/EBPalpha (CCAAT/enhancer binding protein a) and the tumor suppressor p53. Thus, it is possible that UBE21-v5 plays a role in carcinogenesis by suppressing the function of CIEBPa and/or p53 via RPA2-like activity.


Subject(s)
Antineoplastic Agents/pharmacology , Fibroblasts/drug effects , Fibroblasts/enzymology , Ubiquitin-Conjugating Enzymes/physiology , Animals , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/genetics , DNA, Complementary/blood , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , Esophageal Neoplasms/blood , Esophageal Neoplasms/enzymology , Esophageal Neoplasms/genetics , Etoposide/pharmacology , Fibroblasts/physiology , Genes, ras , Mice , Mitoxantrone/pharmacology , NIH 3T3 Cells , Transfection , Ubiquitin-Conjugating Enzymes/biosynthesis , Ubiquitin-Conjugating Enzymes/genetics , Ubiquitin-Conjugating Enzymes/metabolism , Vincristine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...